EPCAM and neoplasm: Microfluidic devices with multiple antigen binding capacity have also been developed for rapid enrichment of EVs from the blood, and often include epithelial cell adhesion molecule (EpCAM) along with various other surface proteins shown to be upregulated in different tumours.